Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion evidence source_evidence_literature NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion SIO_000772 15000491 NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion wasDerivedFrom befree-20140225 NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion wasGeneratedBy ECO_0000203 NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.